| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Anatomy and Histology and Institute for Biomedical Research (F13), The University of Sydney, Sydney, New South Wales, Australia 2006.
PURPOSE. In a previous study, it was determined that TGFß induces cataractous changes in the rat lens in vitro. The purpose of the present study was to determine whether the introduction of biologically active TGFß into the vitreous stimulates cataractous changes in the rat lens in situ.
METHODS. TGFß was injected into the vitreous of the left eye of anesthetized adult male Wistar rats. The right eye received sterile vehicle as a control. Three to four months after injection, animals were killed, and lenses were enucleated and examined for cataractous changes.
RESULTS. All lenses from control eyes remained transparent and maintained normal cellular architecture throughout. In contrast, lenses from TGFß-injected eyes displayed cloudiness in the cortex. In some lenses, distinct opacities were also apparent at the equator and extending some distance toward the anterior and posterior poles. Histologically, the opacities corresponded to subcapsular plaques containing aberrant cells and accumulations of extracellular matrix. In addition, cortical fibers in the anterior and posterior of all lenses displayed variable degrees of swelling, and many retained their nuclei. In some regions, the fiber cells appeared to have degenerated to form large homogeneous areas. The cellular architecture of the equator of these lenses was also disrupted and, in the most severe case, no bow zone was apparent with nucleated cells extending to the posterior pole.
CONCLUSION. The introduction of active TGFß into the vitreous induced lenses to undergo cataractous changes. In addition to the TGFß-induced changes in the epithelium that were reported previously, cataractous changes observed in this study also involved the lens fiber cells and resembled changes observed in human posterior subcapsular and cortical cataracts.
This article has been cited by other articles:
|
|
 |
|
  S. Kase, J. G. Parikh, P. N. Youssef, A. L. Murphree, and N. A. Rao Transforming Growth Factor {beta} in Retinoblastoma-Related Cataract Arch Ophthalmol, November 1, 2008; 126(11): 1539 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Hodgkinson, G. Duncan, L. Wang, C. J. Pennington, D. R. Edwards, and I. M. Wormstone MMP and TIMP Expression in Quiescent, Dividing, and Differentiating Human Lens Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lois, J. Taylor, A. D. McKinnon, G. C. Smith, R. van't Hof, and J. V. Forrester Effect of TGF-{beta}2 and Anti-TGF-{beta}2 Antibody in a New In Vivo Rodent Model of Posterior Capsule Opacification Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4260 - 4266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Sachdev, N. Di Girolamo, T. M. Nolan, P. J. McCluskey, D. Wakefield, and M. T. Coroneo Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Human Lens: Implications for Cortical Cataract Formation Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4075 - 4082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lois, R. Dawson, A. D. McKinnon, and J. V. Forrester A New Model of Posterior Capsule Opacification in Rodents Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3450 - 3457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Younan, P. Mitchell, R. G. Cumming, J. Panchapakesan, E. Rochtchina, and A. M. Hales Hormone Replacement Therapy, Reproductive Factors, and the Incidence of Cataract and Cataract Surgery: : The Blue Mountains Eye Study Am. J. Epidemiol., June 1, 2002; 155(11): 997 - 1006. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
